Aarkstore Market Research Report - Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth

1
Aarkstore Market Research Report - Type 2
Diabetes Therapeutics in Asia-Pacific Markets to
2020 - Increasing Uptake of Novel Drug Classes to
Drive Market Growth
To buy this Report Visit http//www.aarkstore.com

2

Discounted Market Research Reports available on
Aarkstore.com Offer valid till 28th February,
2015 For more inquiries, contact at 91
9987295242 / 022-27564953 Email
enquiry_at_aarkstore.com
To buy this Report Visit http//www.aarkstore.com

3
Summary

•  GBI Research, the leading business intelligence
  provider, has released its latest research, Type
  2 Diabetes Therapeutics in Asia-Pacific Markets
  to 2020 - Increasing Uptake of Novel Drug Classes
  to Drive Market Growth, which provides insights
  into type 2 diabetes in the Asia-Pacific (APAC)
  markets of China, India, Japan and Australia. The
  report estimates the market size for 2013 and
  provides a forecast until 2020, and covers
  disease epidemiology, treatment algorithms, and
  treatment use patterns. It also provides in-depth
  analysis of the pipeline molecules, clinical
  trial failure rates, and recent deals. The report
  has been built using data and information sourced
  from proprietary databases, primary and secondary
  research and in-house analysis carried out by GBI
  Researchs team of industry experts.  In 2013,
  the value of the type 2 diabetes therapeutics
  market in APAC countries was an estimated 6.5
  billion, and it is forecast to grow at a Compound
  Annual Growth Rate (CAGR) of 7.1 between 2013
  and 2020 to 10.5 billion. This strong growth is
  due to the anticipated approval of products in
  relatively novel treatment classes, such as
  Glucagon-Like Peptide-1 (GLP-1) agonists,
  Dipeptidyl Peptidase-4 (DPP-4) inhibitors, and
  Sodium Glucose Transporter-2 (SGLT-2) inhibitors,
  as well as the growth of the prevalence
  population in the APAC region, particularly in
  India and China. 

4
Scope

• The report analyzes the treatment use patterns,
  market characterization, pipeline analysis and
  key licensing and co-development deals of the
  type 2 diabetes in the APAC markets of China,
  India, Japan, and Australia.It includes - - A
  brief introduction to type 2 diabetes, including
  its pathophysiology, etiology, diagnosis and
  treatment algorithms- In-depth analysis of
  currently marketed drugs for type 2 diabetes,
  including analysis of their safety, efficacy,
  treatment patterns, and strengths and weaknesses,
  as well as a heat map comparing them in terms of
  safety and efficacy- A comprehensive review of
  the pipeline for type 2 diabetes, including
  individual analysis of a number of late-stage
  pipeline drugs that are likely to enter the
  market during the forecast period the pipeline
  is analyzed by Phase distribution, molecule type,
  program type, mechanism of action and molecular
  target- Additional in-depth analysis of pipeline
  drug clinical trials by Phase, trial size, trial
  duration and program failure rate for each
  molecule type

5
Scope

• - Multi-scenario market forecast data to 2020,
  taking into account how the market might be
  affected by the introduction of new drugs, the
  expiry of key patents on current drugs, and the
  changes in disease epidemiology across the key
  developed markets- Discussion of the drivers of
  and barriers to market growth- In-depth analysis
  of all licensing and co-development deals that
  have occurred in the type 2 diabetes market since
  2006
• To know more about this report click here
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/81464/type-2-diabetes-therapeutics-in-asia-pacif
  ic-markets

6

Reasons To Buy

• The report will enhance your decision-making
  capability by allowing you to - - Understand the
  type 2 diabetes pipeline and the factors that
  indicate that it is becoming more innovative-
  Examine detailed profiles for promising pipeline
  products and gain an insight into how and with
  whom they are likely to compete in the market-
  Follow the trends in type 2 diabetes clinical
  trial size and duration in relation to industry
  averages- Assess the potential risk of future
  developmental programs for type 2 diabetes
  therapeutics, depending on the mechanism of
  action, by taking into account the recorded
  clinical trial failure rates- Examine the growth
  patterns expected for the type 2 diabetes market
  over the forecast period and the countries that
  are expected to contribute the most to this
  growth, allowing you to devise a more effectively
  tailored country strategy through an
  understanding of key drivers and barriers-
  Accelerate and strengthen your market position by
  identifying key companies for strategic
  partnerships 

7
Table of Contents
Type 2 Diabetes Therapeutics in Asia-Pacific
Markets to 2020 - Increasing Uptake of Novel Drug
Classes to Drive Market Growth
Marketed Products
Pipeline Analysis by Molecule Type
Deals and Strategic Consolidations
Type 2 Diabetes Market
8
Price Chart

• Type 2 Diabetes Therapeutics in Asia-Pacific
  Markets to 2020 - Increasing Uptake of Novel Drug
  Classes to Drive Market Growth
• Product Price

License Type Price
PDF 4995
Site License  9990
Enterprise Wide Licence  14985
Click Here
To View OR Purchase Report
9
Related Market Research Report

• Generic Drugs Market in Japan 2015-2019
• Lung Cancer-Global API Manufacturers, Marketed
  and Phase III Drugs Landscape, 2015
• Metastatic Brain Tumor-Global API Manufacturers,
  Marketed and Phase III Drugs Landscape, 2015
• Lupus Erythematosus-Global API Manufacturers,
  Marketed and Phase III Drugs Landscape, 2015
• Metastatic Breast Cancer-Global API
  Manufacturers, Marketed and Phase III Drugs
  Landscape, 2015
• Malaria-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015

10

• Metastatic Colorectal Cancer-Global API
  Manufacturers, Marketed and Phase III Drugs
  Landscape, 2015
• Melanoma-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015
• Metastatic Hormone Refractory (Castration
  Resistant, Androgen-Independent) Prostate
  Cancer-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015
• Meningitis-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015
• Pharmaceuticals Healthcare Market Research
  Reports

11
About Aarkstore Enterprise

• Aarkstore Enterprise provides Industry and Market
  Analysis and Research Report with expertise and
  technology knowledge on business improvement and
  market acquisition.
• Aarkstore achieved its debut pad in the year 2008
  to explore, work on assignments and cater
  worldwide clients and business giants with
  business research on trends, markets and
  technologies. The latest set of applications
  guarantees active analysis and Market Research
  understanding for budding enterpriser and
  consultants to relate industry ground research.

12
Contact Us

• Office
• Office No. - 809, 8th Floor,
• B-Wing, Mahaavir Icon, 
• Plot No.- 89 90, Sector-15,
• CBD-Belapur, Navi Mumbai 400614, 
• Maharashtra, India.
• Telefax No 91 22 4127 6660
• 24/7 Online Support 91 9987295242
• General Inquiries 91 - 22 2756 4953

You Can Visit http//www.aarkstore.com OR Mail
us at contact_at_aarkstore.com Blog
http//www.aarkstore.com/blog/ Conference
http//conference.aarkstore.com/ News
http//www.aarkstore.com/news